Controlled Substance Market - Opportunities, Share, Growth and Competitive Analysis and Forecast 2029
Designed to support strategic planning, this report breaks down key metrics and trends across the controlled substance sector.
Controlled Substance Market Analysis & Forecast: 2025-2029
The controlled substance market size has grown strongly in recent years. It will grow from $94.86 billion in 2024 to $100.19 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to medical advancements, regulatory frameworks, rising incidence of chronic diseases, expanding pharmaceutical industry, international trade, and collaboration.
The controlled substance market size is expected to see strong growth in the next few years. It will grow to $133.97 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to precision medicine, telemedicine and remote healthcare, opioid alternatives, continued regulatory updates, increased mental health focus. Major trends in the forecast period include regulatory changes and compliance, increasing focus on drug safety and abuse prevention, advancements in drug delivery technologies, emergence of biosimilars and generic versions, integration of digital health solution.
Get your free sample today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9898&type=smp
What Are The Factors Driving The Controlled Substance Market?
The increasing demand for medically prescribed drugs is expected to propel the growth of the controlled substance market going forward. A prescription drug refers to drugs that are intended to be used in the treatment, cure, remediation, therapeutic intervention, or avoidance of illness. Prescription drugs are commonly included in controlled substances. Prescription drugs are beneficial to the controlled substance market because they can enhance outcomes for patients and minimize wasteful spending. For instance, in September 2024, according to a report shared by the Centers for Medicare and Medicaid Services (CMS), a US-based federal agency, in 2022, spending on prescription drugs increased by 8.4 % to $405.9 billion compared to 6.8% growth in 2021. Therefore, the increasing demand for medically prescribed drugs is driving the growth of the controlled substance market.
What Segments Are Covered In The Controlled Substance Market Report?
The controlled substance market covered in this report is segmented –
1) By Drug: Opioids, Stimulant, Depressants, Cannabinoids
2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
3) By Application: Pain Management, Sleep Disorders, Depression And Anxiety, Seizure, Attention Deficit Hyperactivity Disorder (ADHD), Other Applications
Subsegments:
1) By Opioids: Natural Opioids, Semi-Synthetic Opioids, Synthetic Opioids
2) By Stimulants: Amphetamines, Methylphenidate, Cocaine
3) By Depressants: Benzodiazepines, Barbiturates, Sleep Medications
4) By Cannabinoids: THC (Tetrahydrocannabinol), CBD (Cannabidiol), Synthetic Cannabinoids
What Are The Main Trends, Positively Impacting The Growth Of Controlled Substance Market?
Product innovations are a key trend gaining popularity in the controlled substance market. Major companies operating in the controlled substance market are innovating new products and drugs to sustain their position in the market. For instance, in January 2022, CMM (CareFlow Medicines Management Ltd.), a UK-based provider of medicine management solutions, partnered with an Australia-based healthcare software provider, Modeus, to launch its Controlled Drug Manager (CD Manager). It is an innovative controlled drug management platform designed to safely manage and track controlled drugs, including patients own drugs. The brand-new CMM CD Manager, powered by Modeus, will be able to interact with both CMM's platform for managing medications and other external systems. It has been created for usage by clinical personnel and pharmacists in the pharmacy, wards, and theatres of hospitals where regulated medications are kept. Using built-in reporting, CD Manager specifically assists Controlled Drug Accountable Officers in tracking the life cycle of controlled drugs within an organization and taking prompt action in response to automated warnings on inconsistencies or probable diversion.
Which Are The Major Players Operating In The Global Controlled Substance Market?
Major companies operating in the controlled substance market include Merck & Co. Inc., Johnson and Johnson Services Inc., Orbis Biosciences Inc., GW Pharmaceuticals plc, Corium Inc., Aradigm Corporation, Alkermes plc, Sun Pharmaceutical Ltd., F. Hoffmann-La Roche Ltd., AbbVie Inc., Ampac Fine Chemicals, Siegfried Holding AG, Pfizer Inc., Novartis AG, GlaxoSmithKline plc, Sanofi S.A., Bristol-Myers Squibb, Eli Lilly and Company, AstraZeneca, Teva Pharmaceutical Industries, Viatris Inc., Boehringer Ingelheim, Gilead Sciences, Amgen, Regeneron Pharmaceuticals, Abbott Laboratories, Mallinckrodt Pharmaceuticals, Endo International, Catalent, Cambrex Corporation, Lonza Group, Indivior plc, Ipsen SA
View the full controlled substance market report here:
https://www.thebusinessresearchcompany.com/report/controlled-substance-global-market-report
Controlled Substance Market Regional Insights:
North America was the largest region in the controlled substance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the controlled substance market report during the forecast period. The regions covered in the controlled substance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
#Contact Us:#
The Business Research Company
https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
#Follow Us On:#
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment